Adult stem cell therapy is enjoying widespread success around the world, but if the FDA gets its way, it may soon be banned here in the U.S....
There have been nearly 12,000 adult stem cell therapies performed in the United States with an over 90 percent success healing rate for mostly joint and spinal conditions. It involves using the patients own stem cells, so no patent-able drugs are involved.
They are targeting the most influential stem cell scientist in the U.S., Dr. Kristin Comella in Florida.
Differentiating the Types of Stem Cell Therapy
They could be considered seeds for growing body tissues. They are mostly able to function for cellular repair and growth no matter what organ is in need of repair or healing from chronic inflammation.
There is a considerable controversy surrounding stem cell therapy research, a branch of regenerative medicine. Much of the controversy has to do with not differentiating between adult stem cell therapy and embryonic stem cell therapy.
Read: Scientists Discover That Fasting Triggers Stem Cell Regeneration & Fights Cancer
Embryonic stem cell therapy is the controversial one. It cultures or creates stem cells from terminated or aborted fetuses.
Currently, the FDA is harassing stem cell clinics that do not derive their stem cell solutions from aborted fetus tissue. They extract the stem cells from the patients own adipose tissue and inject them into areas where that same patient needs repair. Its an autologous process called adult stem cell therapy.
U.S. Stem Cell based out of South Florida is one of the clinics being targeted by the FDA, and the clinics Chief Scientist is Dr. Kristin Comella, PhD.
Many other nations have been using adult stem cell therapy successfully over the past 15 years, leaving the USA dead last in this field. The FDA is trying to make sure it stays that way and allows costly pharmaceutical versions to prevail.
Dr. Kristin Comella and her clinic have been under attack from the FDA.
This short 3-minute video was produced interviewing Dr. Comella and some of her patients.
Examining and Comparing the Different Types of Stem Cell Therapy
Human embryonic stem cell (hESC) therapy has received most of the medias attention and government support. But it is the most controversial because it involves extracting tissues from terminated human embryos, aka aborted fetuses.
In addition to moral and ethical issues, human embryonic stem cell (hESC) solutions create cells so rapidly where theyre injected they lead to cancerous tumors. To avoid that, researchers have to use immuno-suppressant drugs to curb the embryonic stem cells tendency toward cancer.
Using pharmaceutical drugs to curb hESC cancer side effect issues leads to other unexplored and unexpected side effects from those patented stem cell solutions.
But the profit motive for embryonic stem cell therapies was strong and a lot of government funds had been put into its research. Pharmaceutical companies were motivated because they could patent stem cells created from embryonic tissues.
Bone marrow stem cell therapy was among the first to depart from flawed hESC (human embryonic stem cell) therapies developed over the past two decades. Bone marrow stem cell therapy was the segue into the adult stem cell therapy movement.
Bone marrow extractions are painful, requiring general anesthesia. Its relatively difficult and expensive compared to adipose (fat) tissue stem cell harvesting.
Bone marrows high white blood cell count also encourages inflammation, making it counter-productive for patients already suffering from chronic inflammation or autoimmune disorders.
Most importantly, adipose (fat) tissue yields up to 500 times more mesenchymal stem cells than bone marrow sources, according to Dr. Comella. These are potent stem cells that can differentiate into a wide variety of other cell types. Furthermore, the adipose white blood cell count is lower than bone marrow matter.
Overactive, confused immune responses attack organs continually and create chronic inflammation and autoimmune diseases. The lower white blood cell count automatically lowers the risk of further inflammation among patients already suffering from chronic inflammation and autoimmune diseases.
The outpatient treatment involves creating a very small and shallow incision that wont require stitches on an area of skin covering adipose tissue (fat). From there, liposuction can withdraw a portion of the fat. This part of the procedure requires only a local anesthetic.
Then what is extracted is spun at high speed in a special centrifuge to isolate the stem cells which are then purified for IV drip delivery or injection into the same patient from whom it was extracted. Total costs range from five to ten thousand dollars or more in some cases.
Dr. Comella and her colleagues mission is to get adult stem cell therapy available for everyone. Private and government health insurance providers cover medical treatments that are much more expensive.
Why not cover one that would save money with its lower expense and fewer side effects?
Over the years, there have been nearly 12,000 adult stem cell therapies performed in the United States with an over 90 percent success healing rate for mostly joint and spinal conditions as well as heart and lung issues.
But the three known adverse side effect cases continually get all the media attention.
The Panama College of Cell Science, which helped launch Kristin Comellas research and development, had this to say about her:
"Perhaps the most influential clinician on the subject of adult stem cell therapy, Dr. Comella has been able to quietly develop patient treatment protocols and treat patients via collaborating physicians and health care providers using legal patient-specific FDA guidelines, including studies permitted by Institutional Review Boards, patient-specific stem cell clinical trials, and direct treatments using the patients own stem cells that are harvested and re-injected for therapeutic purposes.
"Through Dr. Comellas leadership, she and her team have trained and certified more than 700 physicians worldwide in adult stem cell therapy." (Source)
The interview below allows the energetic Dr. Kristin Comella to give a thorough and upbeat description of adult stem cell therapy.
Big Pharma Is Using the FDA to Eliminate Unregulated Adult Stem Cell Competition
Since the late 1990s, adult stem cells used therapeutically were not under the control of the FDA and the adult stem cell movement took off.
There were complaints from some MDs that the adult stem cell practice should be regulated by the FDA. The Panama College of Cell Science responded to those outcries with this statement:
"The motive in opposing adult stem cell therapy is money. The big institutions want to keep federal funding of embryonic stem cell research at a high level with the promise that cures are just around the corner despite the fact that embryonic stem cells will never be useful in any way for patient treatment because they immediately cause tumors when transplanted." (Source)
Adult stem cell therapy is an autologous treatment method. The stem cells are not lab-created. They are only isolated and purified after extracting them from the patient being treated. Injecting them back into that patient powers up the bodys own healing mechanism to overcome chronic ailments.
The FDA didnt and shouldnt have anything to do with regulating stem cells from ones own body. That situation has recently been arbitrarily and suddenly changed.
Around 2014, the FDA started tweaking their guidance rules for stem cell therapy with the purpose of getting new rules made into laws through Congress that could be interpreted according to FDA whims and enforced arbitrarily. Their agenda is to consider adult stem cells as FDA-regulated drugs.
During our phone conversation, Dr. Comella explained how the FDA ignored testimonies from adult stem cell practitioners during their 2015 public hearings regarding new guideline proposals. Then they arranged to create new rules behind closed door meetings that included pharmaceutical industry allies and insiders.
The result was that by 2017, the FDAs hands-off policy with adult stem cell therapy came to a sudden halt after years of highly successful stem cell practice.
By 2018, the FDA got nastier with the the most influential clinician on the subject of adult stem cell therapy as its target. The FDA started doing inspections of Dr. Comellas South Florida clinic that are designed for labs that manufacture drugs.
The standards for hospitals and clinics are not as strict as drug manufacturers. Those inspections were inappropriate for a clinic. But those inspections made it easier to create damaging reports.
When the inspectors came by, they demanded to go into rooms while treatments were taking place with semi-nude or nude patients, which Dr. Comella prohibited. The inspectors also demanded to view patient medical records. She allowed that after redacting their names on the copies she gave them.
For her actions to protect patients privacy, inspectors allegedly cited Dr. Comella for resisting and obstructing FDA inspections.
Soon after the inspections, the FDA served Dr. Comella with a lawsuit for practicing medicine with unapproved drugs. The drugs were only those stem cell solutions drawn from patients to be used on them.
The FDA has allegedly offered to drop the lawsuit if Dr. Comella signed an agreement to stop doing adult stem cell therapy and no longer promote it.
She refused. She said she has witnessed people leave their wheelchairs for good from this therapy. The trial is set for a Federal Court hearing beginning June 2019, in Miami, Florida.
If Dr. Comella loses this court case, adult stem cell therapy in the USA may be forced out of the country and only be available to those who can afford medical tourism.
Reference: HealthImpactNews.com
Read more:
Adult Stem Cell Therapy Is A Resounding Healing Success ...
- May is Melanoma and Skin Cancer Awareness Month. Keep up with the latest news on skin in the Dermatology channel - Newswise - May 17th, 2023
- Cell Organ and Preservation Market Size Estimated to Reach US$ 567.31 Million by 2032 Globally, at a CAGR of - EIN News - May 9th, 2023
- Human tissues to be grown in microgravity conditions aboard the ISS - E&T Magazine - August 30th, 2021
- Saudi Arabia Health Insurance Market Size, Share, Competitive Analysis and Growth by 2026 The Manomet Current - The Manomet Current - July 6th, 2021
- Biobanks Market | Prominent Factors Analysis that will Help in Reshaping the Market Growth - BioSpace - February 4th, 2021
- Update on the latest sports - Newscenter1.tv - December 3rd, 2020
- Update on the latest sports-UPDATED - Newscenter1.tv - December 3rd, 2020
- Stem Cell Tourism: Providing Hope For Treatment Away From ... - November 10th, 2020
- Medical Tourism - Stem Cells Transplant Institute - November 10th, 2020
- Anti-Aging Market Research Report: By Product, Treatment, Demography - Global Industry Analysis and Growth Forecast to 2030 - PRNewswire - November 10th, 2020
- Regenerative Medicine Market 2020: Analysis, Top Companies, Size, Share, Demand and Opportunity To 2025 - Eurowire - November 10th, 2020
- Prop. 14: In the COVID age, can California still afford its stem cell research program? - CALmatters - October 15th, 2020
- Stem Cell Research on the Ballot: A Closer Look at Prop 14 - Fullerton Observer - October 15th, 2020
- Sorrento Adds Mesenchymal Stem Cell Program (MSC) That Has Been Cleared for a Phase 1 Trial by the FDA to the Pipeline of COVID-19 Focused Rescue... - October 15th, 2020
- AIVITA Biomedical's Stem Cell Therapeutic in Vision Loss Published in Investigative Ophthalmology & Vision Science - PRNewswire - October 15th, 2020
- UofL-born company secures an additional $115 million to advance cell therapy - uoflnews.com - October 15th, 2020
- Was Trump's Regeneron 'Cure' Developed Using Stem Cells and Fetal Tissues? - Snopes.com - October 15th, 2020
- Novellus Therapeutics Exclusively Licenses Induced Mesenchymal Stem Cells (iMSCs) to NoveCite for COVID-19 Related Acute Respiratory Distress Syndrome... - October 15th, 2020
- Bone Therapeutics' allogeneic cell therapy product, ALLOB, shows 90% fusion rate at 24 months in Phase IIa study in lumbar spinal fusion -... - October 15th, 2020
- Thalassemia Treatment Market projected to expand at a CAGR of 7.9% from 2018 to 2026 - The Daily Chronicle - September 30th, 2020
- Indian Biotechnology Market Market scrutinized in the new analysis - WhaTech - September 22nd, 2020
- Why Are There Only 10 Cell and Gene Therapies in... - Labiotech.eu - September 22nd, 2020
- County seeking broadband need response - Mount Airy News - September 13th, 2020
- Colorado woman arrested for Assault in the Second Degree and Resisting Arrest - Maui Time - September 13th, 2020
- ProgenCell - Stem Cell Therapies announces new facilities - PR Web - August 28th, 2020
- Autologous Cell Therapy Market Along With Covid-19 Impact Analysis and Business Opportunities Outlook 2027 - Scientect - August 25th, 2020
- Candle Lit Tour and New Outdoor Exhibits Coming to the Baldwin Home Museum - Maui Time - August 22nd, 2020
- Deals Under the Radar: These Are the Israeli Tech Companies Already Operating in the UAE - Algemeiner - August 22nd, 2020
- Cell Separation Technology Market is Anticipated to Expand at a CAGR of ~ 12% during 2019 2027 - Press Release - Digital Journal - July 11th, 2020
- Impact Analysis of COVID-19 on Stem Cells Market Study 2018-2028 Segmented On The Basis of Product Type, Geographical Analysis, Future Forecast,... - July 11th, 2020
- Facial Injectable Market Growth Analysis, Size Projection, Key Insights, COVID-19 Impact Analysis and Future Trends By 2025 - Cole of Duty - July 10th, 2020
- Are Hispanics Victims of Inequities in COVID-19 Epidemic? - Bacon's Rebellion - July 10th, 2020
- Spanish antibody study shows 5% of population exposed to coronavirus - ETHealthworld.com - July 9th, 2020
- Infection Control in Cancer Therapy Market (impact of COVID-19) Growth, Overview with Detailed Analysis 2020-2026| Kimberly Clark Corporation, 3M... - July 9th, 2020
- Detector Switches Market Growth By Manufacturers, Type And Application, Forecast To 2026 - 3rd Watch News - July 7th, 2020
- Global Plasma Therapy Market: Industry Size, Growth, Analysis And Forecast of 2023 - 3rd Watch News - July 7th, 2020
- Maui Detective Melvin R Johnson Arrested for OUI 4th of July - Maui Time - July 7th, 2020
- Cell Separation Technology Market by Leading Manufacturers, Demand and Growth Overview 2019 to 2027 - Jewish Life News - July 3rd, 2020
- Spinal Cord Trauma Treatment Market Size : Technological Advancement and Growth Analysis with Forecast to 2025 - 3rd Watch News - June 29th, 2020
- THAILAND'S EXCEPTIONAL STRENGTHS AS THE WORLD'S MEDICAL HUB - Bangkok Post - June 20th, 2020
- Stem cell treatment during COVID-19? This story will give your tear ducts a workout - Sydney Morning Herald - June 12th, 2020
- Thalassemia Treatment Market: Chelation Therapy to be Highly Lucrative Segment - BioSpace - June 12th, 2020
- Coronavirus Today: Protesting and COVID-19 - Los Angeles Times - June 4th, 2020
- Life celebrates 20th anniversary during English Tourism Week - North East Times - May 27th, 2020
- Amid the COVID-19 crisis and the looming economic recession, the Organ and Tissue Transplantation market worldwide will grow by a projected 30.8... - May 27th, 2020
- Live Updates: Coronavirus in the Bay Area - KQED - March 28th, 2020
- Covid-19s Impact in the U.S. - The New York Times - March 28th, 2020
- 15 Good News Stories To Tackle The COVID-19 Sadness - IFLScience - March 21st, 2020
- How the national state of emergency will affect the economy - IOL - March 21st, 2020
- Brekky Wrap: Businessman Failed To Pull Over In Police Chase Because He Was 'Having Sex In The Back Seat' - 10 daily - March 10th, 2020
- Story of Theresa's 'Schule Bell' to be recognized by historic marker - NNY360 - March 3rd, 2020
- 4 ways to soak up the Cape Town summer - IOL - March 3rd, 2020
- All you need to know about cosmetic surgery in UAE - Gulf News - February 21st, 2020
- Building a 'doomsday vault' to save the kangaroo and koala from extinction - CNET - February 20th, 2020
- Top 10 Destinations for Stem Cell Therapy around the World - February 20th, 2020
- Build a & # 39; vault of the end of the world & # 39; to save the kangaroo and the koala from extinction - NewsDio - February 20th, 2020
- 'A stronger B.C., for everyone': Read the full text of the B.C. Budget 2020 speech - CTV News - February 20th, 2020
- Stem Cell Assay Market Booming by Size, Revenue, Trend and Top Growing Companies 2026 - Vital News 24 - January 25th, 2020
- Cell Separation Technology Market Statistics, Demand and Forecasts to 2027 Examined in New Research Report - Dagoretti News - January 25th, 2020
- UFO Religion the Ralians Know They're 'Quite Out There' - VICE UK - January 25th, 2020
- Doctor's Hospital focused on incorporation of AI and machine learning - EyeWitness News - January 17th, 2020
- 26 destinations in Europe that were ruined by tourists over the past decade - INSIDER - January 17th, 2020
- Faculty Highlights: Recent Grants and Awards | Now - Drexel Now - January 17th, 2020
- Asia is where health investors are making money this year - Stockhead - January 17th, 2020
- Smart Luggage Market: Analysis and In-depth Study on Market Size Trends, Emerging Growth Factors and Forecasts to 2022 - Fusion Science Academy - January 17th, 2020
- The top 45 stories of the decade - ISRAEL21c - December 30th, 2019
- Global Cell Culture Media Market 2019 Analysis Sigma-Aldrich, Corning (Cellgro), Life Technologies and Thermo Fisher - Business Broker - December 18th, 2019
- Blue Origin Launches Its First Space Tourism Rocket In Seven Months - And Hopes To Take Humans To Space In 2020 - Forbes - December 15th, 2019
- Cell Separation Technology Market Overview, Growth Forecast, Demand and Development Research Report to 2027 - VaporBlash - December 15th, 2019
- Why Virgin Galactic Stock Just Jumped Another 11% - Nasdaq - December 10th, 2019
- Every 13th man has a hair transplant according to Bookimed study - PR Web - December 1st, 2019
- Cell Separation Technology Market Growth Forecast through 2019-2027 with Upcoming Trends and Market Opportunities - Montana Ledger - November 21st, 2019
- Costa Rica sets the foundations with development potential in the Fourth Industrial Revolution - Q Costa Rica News - November 8th, 2019
- The 901: Landing 'College GameDay' is another in a string of wins for Memphis - Commercial Appeal - October 30th, 2019
- 8 Small Business Owners On What Its Really Like To Start Your Own Company - Yahoo Lifestyle - October 22nd, 2019
- The Aesthetic Medicine Congress to bring trends in plastic surgery to Dubrovnik - The Dubrovnik Times - October 11th, 2019
- Are Stem Cell Tourism and Other Experimental Treatments ... - May 14th, 2019
- Stem Cell Tourism and the Political Economy of Hope - May 13th, 2019
- 'Stem-cell tourism' needs tighter controls, say medical ... - May 9th, 2019
- Stem Cell Treatment in India | Stem Cell Therapy in Uttar ... - May 2nd, 2019